Kremers Urban plans new financing for acquisition by Advent and Avista

By Sara Rosenberg

New York, Nov. 7 – Kremers Urban Pharmaceuticals Inc. plans on getting financing led by Credit Suisse Securities LLC, Morgan Stanley & Co. LLC, Goldman Sachs & Co and Jefferies LLC to help fund its buyout, according to a news release.

The company is being purchased by Advent International and Avista Capital Partners from UCB SA for $1,525,000,000.

Closing is expected by the first quarter of 2015, subject to regulatory approval and other customary conditions.

Kremers Urban is a Princeton, N.J.–based specialty generic pharmaceuticals company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.